Literature DB >> 15845219

Mitochondrial mutagenesis and oxidative stress in human prostate cancer.

Junjian Z Chen1, Fred F Kadlubar.   

Abstract

Prostate cancer is the most common cancer diagnosed in men in the United States, but the primary cause and the molecular events leading to prostate carcinogenesis are poorly understood. Using the approach of laser capture microdissection, we revealed extensive somatic mitochondrial DNA (mtDNA) mutations in prostatic neoplastic lesions. Inspection of the lesion associated mutations not only provided new insights into the genetics of prostate cancer, but also revealed new patterns of mtDNA mutation in prostate carcinogenesis. Further analysis on a high frequency of multiple mutational events observed in the same neoplastic lesion revealed an unusually rapid process in mitochondrial mutagenesis, suggesting a new process of mitochondrial hyper-mutagenesis in cancer cells, likely mediated by cellular oxidative stress. Thus, active mitochondrial mutagenesis in prostate cancer suggests a prominent role of increased cellular oxidative stress in neoplastic transformation and the increased susceptibility of neoplastic cells to oxidative damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15845219     DOI: 10.1081/GNC-120037931

Source DB:  PubMed          Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev        ISSN: 1059-0501            Impact factor:   3.781


  15 in total

1.  Selective apoptosis induction by the cancer chemopreventive agent N-(4-hydroxyphenyl)retinamide is achieved by modulating mitochondrial bioenergetics in premalignant and malignant human prostate epithelial cells.

Authors:  Numsen Hail; Ping Chen; Jadwiga J Kepa
Journal:  Apoptosis       Date:  2009-07       Impact factor: 4.677

2.  Mitochondrial DNA exhibits resistance to induced point and deletion mutations.

Authors:  William J Valente; Nolan G Ericson; Alexandra S Long; Paul A White; Francesco Marchetti; Jason H Bielas
Journal:  Nucleic Acids Res       Date:  2016-08-22       Impact factor: 16.971

Review 3.  Mitochondrial DNA mutations in human neoplasia.

Authors:  Anna M Czarnecka; Pawel Golik; Ewa Bartnik
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

Review 4.  Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis.

Authors:  Jianxin Lu; Lokendra Kumar Sharma; Yidong Bai
Journal:  Cell Res       Date:  2009-07       Impact factor: 25.617

5.  Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells.

Authors:  Takatsugu Mizumachi; Levan Muskhelishvili; Akihiro Naito; Jun Furusawa; Chun-Yang Fan; Eric R Siegel; Fred F Kadlubar; Udaya Kumar; Masahiro Higuchi
Journal:  Prostate       Date:  2008-03-01       Impact factor: 4.104

6.  Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice.

Authors:  Avantika Barve; Tin Oo Khor; Sujit Nair; Kenneth Reuhl; Nanjoo Suh; Bandaru Reddy; Harold Newmark; Ah-Ng Kong
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

7.  Mitochondria and familial predisposition to breast cancer.

Authors:  Stefania Weigl; Angelo Paradiso; Stefania Tommasi
Journal:  Curr Genomics       Date:  2013-05       Impact factor: 2.236

8.  Mitochondrial haplogroups and polymorphisms reveal no association with sporadic prostate cancer in a southern European population.

Authors:  María Jesús Álvarez-Cubero; María Saiz Guinaldo; Luís Javier Martínez-González; Juan Carlos Álvarez Merino; José Manuel Cózar Olmo; José Antonio Lorente Acosta
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

9.  Analysis of differential DNA damage in the mitochondrial genome employing a semi-long run real-time PCR approach.

Authors:  Oliver Rothfuss; Thomas Gasser; Nadja Patenge
Journal:  Nucleic Acids Res       Date:  2009-12-04       Impact factor: 16.971

10.  Simultaneous quantification of mitochondrial DNA damage and copy number in circulating blood: a sensitive approach to systemic oxidative stress.

Authors:  Sam W Chan; Simone Chevalier; Armen Aprikian; Junjian Z Chen
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.